Latest News for Sirona Biochem Stock (OTC:SRBCF)

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.

News

Guidance

Contracts

Management

Global

SRBCF

Sirona Biochem Hires Investor Relations Firm Consulting to Increase Awareness in US

SIRONA BIOCHEM CORP ORD by Sirona Biochem Corp.

Sirona Biochem Corp

Press Releases

General

Sirona Biochem Corporate Update January 2024

Sirona Biochem Initiates Private Placement

Financing

Sirona Biochem Announces Loan

Sirona Biochem Engages Global Beauty Consulting

Sirona Biochem Provides Update on Loan

Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim™ in Early 2025

Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

Sirona Biochem Announces 2023 Annual Meeting Results

SIRONA BIOCHEM Corporate Update April 2024

Sirona Biochem Engages Stonegate Healthcare Partners

TSXV:SBM

Sirona Biochem

Biotech

ABBV

Allergan To Develop And Commercialize Topical Skin Care Treatments Based On Active Ingredients Derived From Certain Of Sirona's Patents For TFC-1067 And Related Family Of Compounds

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Sirona Biochem Stock (OTC:SRBCF)

Monday, June 13, 2022

Tuesday, January 22, 2013